Compare HWBK & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HWBK | LAB |
|---|---|---|
| Founded | 1865 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 272.2M | 271.0M |
| IPO Year | 1996 | 2008 |
| Metric | HWBK | LAB |
|---|---|---|
| Price | $38.35 | $0.75 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.35 |
| AVG Volume (30 Days) | 10.0K | ★ 1.6M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.49% | N/A |
| EPS Growth | 31.42 | ★ 61.54 |
| EPS | ★ 1.89 | 0.26 |
| Revenue | N/A | ★ $101,937,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.63 |
| P/E Ratio | $20.23 | ★ $2.81 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $29.42 | $0.63 |
| 52 Week High | $40.60 | $1.72 |
| Indicator | HWBK | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 36.78 | 54.95 |
| Support Level | $38.11 | $0.70 |
| Resistance Level | $40.37 | $1.02 |
| Average True Range (ATR) | 0.99 | 0.04 |
| MACD | -0.17 | 0.01 |
| Stochastic Oscillator | 26.22 | 84.44 |
Hawthorn Bancshares Inc is a financial holding company that, along with its subsidiary bank, provides commercial banking for small and mid sized businesses, including equipment, operating, commercial real estate and SBA loans, and personal banking services such as real estate mortgage lending, installment and consumer loans, certificates of deposit, and checking, savings and money market accounts. It has two segments, banking and wealth management, with the banking segment earning the majority of its revenue and conducting general banking business, offering checking and savings accounts, internet banking, debit cards, certificates of deposit, brokerage services and others. Its primary source of revenue is net interest income derived from lending and deposit taking activities.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.